Clinical trial
Developmental Regulation of Proteins Responsible for Transforming Drugs in the…
NCT00117715 · Children's Mercy Hospital Kansas City, Other · Completed
Key facts
| NCT number | NCT00117715 |
|---|---|
| Title | Developmental Regulation of Proteins Responsible for Transforming Drugs in the Body |
| Official title | Developmental Regulation of CYPs 1A2, 2D6, 3A4 |
| Lead sponsor | Children's Mercy Hospital Kansas City, Other |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Healthy |
| Intervention type | Procedure |
| Interventions | Genotyping and Phenotyping using dextromethorphan and caffeine as probes |
| Enrollment | 121 |
| Start date | Oct 1, 2000 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Jul 8, 2005 |
| Last update posted | Sep 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: